Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
STRONG BUY! Kurs eskaliert - A Star is Born!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3D4A5 | ISIN: CA3638821015 | Ticker-Symbol: W9F
Frankfurt
21.01.25
15:29 Uhr
0,025 Euro
-0,001
-2,00 %
Branche
Rohstoffe
Aktienmarkt
Sonstige
1-Jahres-Chart
GALLOPER GOLD CORP Chart 1 Jahr
5-Tage-Chart
GALLOPER GOLD CORP 5-Tage-Chart
ACCESS Newswire
828 Leser
Artikel bewerten:
(2)

Galloper Gold Corp.: Global Business Leader Nader Elm Joins Galloper Gold's Board of Directors

Finanznachrichten News

VANCOUVER, BC / ACCESSWIRE / December 19, 2024 / Galloper Gold Corp. (CSE:BOOM)(OTC PINK:GGDCF) (the "Company" or "Galloper") is pleased to announce the appointment of Mr. Nader Elm to the Company's Board of Directors.

Mr. Elm is a seasoned senior business executive currently residing in Philadelphia, Pennsylvania, who excels at strategic planning, operations and execution, with a focus on technology, media and telecommunications, aerospace and mining. He has brought entrepreneurial and transformational elements from start-ups to multi-billion dollar enterprises.

  • Mr. Elm is Founder of Exyn Technologies Inc., a successful spin-out from the University of Pennsylvania's GRASP Labs leveraging ground-breaking AI robotics research in autonomous navigation for vehicles to execute complex missions in commercial operations;

  • Prior to Exyn, Mr. Elm was Senior VP of Strategy & Corp. Development at IMAX Corporation where he was also General Manager of IMAX Private Theatre which grew rapidly from launch;

  • Prior to IMAX, Mr. Elm was a member of the senior leadership team for Rogers Digital Media, a division of Rogers Communications, where he successfully led the acquisitions and integration of two digital properties;

  • Mr. Elm's earlier experiences also include Director of Corporate Strategy at Bell Canada, Vice-President of Business Development at Blue Spark Media, and Senior Consultant at Boston-based Adventis Consulting.

Mr. Hratch Jabrayan, Galloper CEO, commented: "Nader's business acumen and ability to create and drive value across multiple sectors are skills that have made him a highly successful entrepreneur. I've had the pleasure of knowing Nader for many years and I'm delighted he's agreed to join the Galloper Board. The fact he has connections with many investors around the world, and often travels abroad on business, greatly extends Galloper's reach."

Mr. Elm holds a B.Eng (Hons) from University College London, London University, and an MBA from London Business School.

To make room for Mr. Elm on the Galloper Board, Mr. Bryan Loree has resigned as a Director but remains the Company's Chief Financial Officer. Galloper thanks Mr. Loree for his contributions as a Director.

About Galloper Gold Corp.

Galloper is focused on mineral exploration in the Central Newfoundland Gold Belt with its Glover Island and Mint Pond properties, each prospective for gold and base metals. The Glover Island Property consists of 532 mining claims totaling 13,300 hectares while Mint Pond consists of 499 claims totaling 12,475 hectares.

For more information please visit www.GalloperGold.com and the Company's profile on SEDAR+ at www.sedarplus.ca.

On behalf of the Board of Directors,

Mr. Hratch Jabrayan
CEO and Director
Galloper Gold Corp.

Company Contact:

info@gallopergold.com
Tel: 778-655-9266

Investor Relations:
MarketSmart Communications
Tel: 877-261-4466

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of applicable securities laws. The use of any of the words "anticipate", "plan", "continue", "expect", "estimate", "objective", "may", "will", "project", "should", "predict", "potential" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company cannot give any assurance that they will prove correct. Since forward-looking statements address future events and conditions, they involve inherent assumptions, risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of assumptions, factors and risks. These assumptions and risks include, but are not limited to, assumptions and risks associated with mineral exploration generally, risks related to capital markets, risks related to the state of financial markets or future metals prices and the other risks described in the Company's publicly filed disclosure.

Management has provided the above summary of risks and assumptions related to forward-looking statements in this news release in order to provide readers with a more comprehensive perspective on the Company's future operations. The Company's actual results, performance or achievement could differ materially from those expressed in, or implied by, these forward-looking statements and, accordingly, no assurance can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what benefits the Company will derive from them. These forward-looking statements are made as of the date of this news release, and, other than as required by applicable securities laws, the Company disclaims any intent or obligation to update publicly any forward-looking statements, whether as a result of new information, future events or results or otherwise.

Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Galloper Gold Corp.



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.